Mitchell Kapoor
Stock Analyst at H.C. Wainwright
(4.54)
# 1,017
Out of 4,646 analysts
756
Total ratings
44.3%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGTX MeiraGTx Holdings | Reiterated: Buy | $20 | $12.67 | +57.85% | 5 | Aug 14, 2026 | |
| RNA Atrium Therapeutics | Reiterated: Buy | $25 | $12.33 | +102.76% | 2 | Aug 14, 2026 | |
| SMMT Summit Therapeutics | Reiterated: Hold | n/a | $14.00 | - | 35 | Aug 13, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $5 | $1.93 | +159.07% | 29 | Aug 13, 2026 | |
| NGNE Neurogene | Reiterated: Buy | $70 → $65 | $35.63 | +82.43% | 35 | Aug 12, 2026 | |
| KYTX Kyverna Therapeutics | Reiterated: Buy | $25 | $8.08 | +209.41% | 21 | Aug 12, 2026 | |
| PALI Palisade Bio | Reiterated: Buy | $7 | $2.15 | +225.58% | 5 | Aug 11, 2026 | |
| LEGN Legend Biotech | Reiterated: Buy | $65 | $20.27 | +220.67% | 63 | Aug 11, 2026 | |
| DMRA Damora Therapeutics | Reiterated: Buy | $45 | $30.73 | +46.44% | 4 | Aug 11, 2026 | |
| ALMS Alumis | Reiterated: Hold | $25 | $24.41 | +2.42% | 24 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 575.00 | kr 442.20 | +30.03% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $60 | $68.53 | -12.45% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $115 | $100.67 | +14.23% | 59 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $11.83 | +111.33% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $19.45 | +54.24% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.72 | +186.70% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $13.29 | +12.87% | 23 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $13.74 | +227.51% | 25 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.07 | - | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $15.03 | +66.33% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $18.42 | -72.86% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $2.81 | +77.94% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $55.87 | +105.83% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $53.99 | +48.18% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.02 | +79.86% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $108.12 | +10.99% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $120.52 | +24.46% | 17 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $16.63 | - | 9 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $11 | $3.35 | +228.36% | 30 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $4.96 | +101.61% | 16 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.27 | - | 20 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.78 | +44.14% | 3 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.23 | +469.11% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $2 | $5.63 | -64.48% | 9 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $6.54 | n/a | 1 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $16.96 | n/a | 26 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0022 | n/a | 16 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.7979 | n/a | 24 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.35 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $3.90 | n/a | 6 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.97 | n/a | 8 | Aug 11, 2023 |
MeiraGTx Holdings
Aug 14, 2026
Reiterated: Buy
Price Target: $20
Current: $12.67
Upside: +57.85%
Atrium Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $25
Current: $12.33
Upside: +102.76%
Summit Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.00
Upside: -
Century Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $5
Current: $1.93
Upside: +159.07%
Neurogene
Aug 12, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $35.63
Upside: +82.43%
Kyverna Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $25
Current: $8.08
Upside: +209.41%
Palisade Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
Legend Biotech
Aug 11, 2026
Reiterated: Buy
Price Target: $65
Current: $20.27
Upside: +220.67%
Damora Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $45
Current: $30.73
Upside: +46.44%
Alumis
Aug 11, 2026
Reiterated: Hold
Price Target: $25
Current: $24.41
Upside: +2.42%
Aug 10, 2026
Reiterated: Buy
Price Target: kr 575.00
Current: kr 442.20
Upside: +30.03%
Aug 7, 2026
Reiterated: Hold
Price Target: $50 → $60
Current: $68.53
Upside: -12.45%
Aug 7, 2026
Reiterated: Buy
Price Target: $95 → $115
Current: $100.67
Upside: +14.23%
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $11.83
Upside: +111.33%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $30
Current: $19.45
Upside: +54.24%
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $8.72
Upside: +186.70%
Aug 7, 2026
Reiterated: Buy
Price Target: $15
Current: $13.29
Upside: +12.87%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $13.74
Upside: +227.51%
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $14.07
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $25
Current: $15.03
Upside: +66.33%
Aug 6, 2026
Reiterated: Sell
Price Target: $5
Current: $18.42
Upside: -72.86%
Aug 6, 2026
Reiterated: Buy
Price Target: $5
Current: $2.81
Upside: +77.94%
Aug 5, 2026
Reiterated: Buy
Price Target: $115
Current: $55.87
Upside: +105.83%
Aug 5, 2026
Reiterated: Buy
Price Target: $80
Current: $53.99
Upside: +48.18%
Aug 5, 2026
Reiterated: Buy
Price Target: $45
Current: $25.02
Upside: +79.86%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $108.12
Upside: +10.99%
Aug 3, 2026
Reiterated: Buy
Price Target: $150
Current: $120.52
Upside: +24.46%
Jul 31, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.63
Upside: -
May 11, 2026
Maintained: Buy
Price Target: $17 → $11
Current: $3.35
Upside: +228.36%
Jan 13, 2026
Reiterated: Buy
Price Target: $13 → $10
Current: $4.96
Upside: +101.61%
Jan 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.27
Upside: -
Oct 24, 2025
Reiterated: Buy
Price Target: $4
Current: $2.78
Upside: +44.14%
Oct 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.23
Upside: +469.11%
Aug 19, 2025
Reiterated: Hold
Price Target: $3 → $2
Current: $5.63
Upside: -64.48%
Aug 11, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $6.54
Upside: n/a
Apr 30, 2025
Rated: Hold
Price Target: n/a
Current: $16.96
Upside: n/a
Apr 4, 2025
Rated: Hold
Price Target: n/a
Current: $0.0022
Upside: n/a
Apr 3, 2025
Reiterated: Buy
Price Target: $9
Current: $0.7979
Upside: n/a
Mar 21, 2025
Reiterated: Buy
Price Target: $15
Current: $6.35
Upside: n/a
May 14, 2024
Reiterated: Hold
Price Target: $15
Current: $3.90
Upside: n/a
Aug 11, 2023
Reiterated: Hold
Price Target: n/a
Current: $0.97
Upside: n/a